Literature DB >> 22943883

Chlamydia muridarum enters a viable but non-infectious state in amoxicillin-treated BALB/c mice.

R Phillips Campbell1, J Kintner, J Whittimore, R V Schoborg.   

Abstract

In culture, exposure to penicillin and other stressors induce chlamydiae to enter a non-infectious but viable state termed persistence. Chlamydiae may reenter their normal developmental cycle after stressor removal. Though aberrant RB similar to those present in culture models of persistence have been observed within infected tissues, the existence of persistent chlamydiae has not been definitively demonstrated in vivo. As a result, the role of persistent organisms in pathogenesis is undefined. In order to establish an experimentally tractable model of in vivo persistence, Chlamydia muridarum vaginally-infected mice were gavaged with either water or amoxicillin (amox). Vaginal swabs were collected for chlamydial titration and RNA isolated for quantification of pre-16s rRNA. Uterine tissue was analyzed by transmission electron microscopy (TEM). Although amox-treatment reduced vaginal shedding by >99%, C. muridarum pre-16s rRNA accumulation was unchanged by treatment. These data indicate that the amox-exposed organisms were viable but not infectious. Furthermore, TEM analyses demonstrated that inclusions in amox-treated animals contained primarily large, aberrant RB, but those observed in untreated control animals were normal. Collectively, these data suggest that amoxicillin treatment induces C. muridarum to enter the persistent state in vivo. This model also represents the first experimentally tractable animal model of chlamydial persistence.
Copyright © 2012 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22943883      PMCID: PMC3654801          DOI: 10.1016/j.micinf.2012.07.017

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  37 in total

1.  Chlamydia trachomatis persistence in vitro: an overview.

Authors:  Priscilla B Wyrick
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

2.  Chlamydia trachomatis enters a viable but non-cultivable (persistent) state within herpes simplex virus type 2 (HSV-2) co-infected host cells.

Authors:  Srilekha Deka; Jennifer Vanover; Sophie Dessus-Babus; Judy Whittimore; Mary K Howett; Priscilla B Wyrick; Robert V Schoborg
Journal:  Cell Microbiol       Date:  2006-01       Impact factor: 3.715

3.  Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression.

Authors:  H C Gérard; P J Branigan; H R Schumacher; A P Hudson
Journal:  J Rheumatol       Date:  1998-04       Impact factor: 4.666

4.  Sexually transmitted diseases treatment guidelines, 2010.

Authors:  Kimberly A Workowski; Stuart Berman
Journal:  MMWR Recomm Rep       Date:  2010-12-17

5.  Differences in Chlamydia trachomatis serovar E growth rate in polarized endometrial and endocervical epithelial cells grown in three-dimensional culture.

Authors:  Natalia V Guseva; Sophie Dessus-Babus; Cheryl G Moore; Judy D Whittimore; Priscilla B Wyrick
Journal:  Infect Immun       Date:  2006-11-06       Impact factor: 3.441

6.  Aberrant chlamydial developmental forms in the gastrointestinal tract of pigs spontaneously and experimentally infected with Chlamydia suis.

Authors:  Andreas Pospischil; Nicole Borel; Emdad H Chowdhury; Franco Guscetti
Journal:  Vet Microbiol       Date:  2008-09-13       Impact factor: 3.293

7.  Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis.

Authors:  J D Fortenberry; E J Brizendine; B P Katz; K K Wools; M J Blythe; D P Orr
Journal:  Sex Transm Dis       Date:  1999-01       Impact factor: 2.830

Review 8.  Chlamydia persistence -- a tool to dissect chlamydia--host interactions.

Authors:  R V Schoborg
Journal:  Microbes Infect       Date:  2011-03-31       Impact factor: 2.700

9.  Penicillin induced persistence in Chlamydia trachomatis: high quality time lapse video analysis of the developmental cycle.

Authors:  Rachel J Skilton; Lesley T Cutcliffen; David Barlow; Yibing Wang; Omar Salim; Paul R Lambden; Ian N Clarke
Journal:  PLoS One       Date:  2009-11-06       Impact factor: 3.240

10.  Bactericidal activity of first-choice antibiotics against gamma interferon-induced persistent infection of human epithelial cells by Chlamydia trachomatis.

Authors:  Nathalie Reveneau; Deborah D Crane; Elizabeth Fischer; Harlan D Caldwell
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

View more
  21 in total

1.  Antibody to Chlamydia trachomatis proteins, TroA and HtrA, as a biomarker for Chlamydia trachomatis infection.

Authors:  K Hokynar; S Korhonen; P Norja; J Paavonen; M Puolakkainen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-14       Impact factor: 3.267

2.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

3.  Induction of the Chlamydia muridarum stress/persistence response increases azithromycin treatment failure in a murine model of infection.

Authors:  R Phillips-Campbell; J Kintner; R V Schoborg
Journal:  Antimicrob Agents Chemother       Date:  2014       Impact factor: 5.191

4.  Chlamydial Pre-Infection Protects from Subsequent Herpes Simplex Virus-2 Challenge in a Murine Vaginal Super-Infection Model.

Authors:  Jessica Slade; Jennifer V Hall; Jennifer Kintner; Robert V Schoborg
Journal:  PLoS One       Date:  2016-01-04       Impact factor: 3.240

Review 5.  Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials.

Authors:  Lee Ann Campbell; Michael E Rosenfeld
Journal:  Front Cell Infect Microbiol       Date:  2014-03-21       Impact factor: 5.293

6.  Characterization of serine hydroxymethyltransferase GlyA as a potential source of D-alanine in Chlamydia pneumoniae.

Authors:  Stefania De Benedetti; Henrike Bühl; Ahmed Gaballah; Anna Klöckner; Christian Otten; Tanja Schneider; Hans-Georg Sahl; Beate Henrichfreise
Journal:  Front Cell Infect Microbiol       Date:  2014-02-26       Impact factor: 5.293

7.  Host immune responses after hypoxic reactivation of IFN-γ induced persistent Chlamydia trachomatis infection.

Authors:  Stefan Jerchel; Inga Kaufhold; Larissa Schuchardt; Kensuke Shima; Jan Rupp
Journal:  Front Cell Infect Microbiol       Date:  2014-04-16       Impact factor: 5.293

8.  Commonly prescribed β-lactam antibiotics induce C. trachomatis persistence/stress in culture at physiologically relevant concentrations.

Authors:  Jennifer Kintner; Dawn Lajoie; Jennifer Hall; Judy Whittimore; Robert V Schoborg
Journal:  Front Cell Infect Microbiol       Date:  2014-04-11       Impact factor: 5.293

9.  What's in a word: the use, misuse, and abuse of the word "persistence" in Chlamydia biology.

Authors:  Patrik M Bavoil
Journal:  Front Cell Infect Microbiol       Date:  2014-03-04       Impact factor: 5.293

10.  Porcine epidemic diarrhea virus (PEDV) co-infection induced chlamydial persistence/stress does not require viral replication.

Authors:  Robert V Schoborg; Nicole Borel
Journal:  Front Cell Infect Microbiol       Date:  2014-03-13       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.